DIMERIX LIMITED

ASX: DXB

Sector: Sector:Health Care
Industry group: Industry:Pharmaceuticals, Biotechnology & Life Sciences

DXB News & Analysis

DXBHealth CareCapital Raising4 Sept 20264 September 2026· 2 min read

Dimerix (ASX: DXB) Secures A$34 Million Clinical Funding Facility

Dimerix will initially draw A$17 million from a A$34 million facility to fund its kidney-disease clinical programs. The debt carries 10% annual interest and milestone participation rights.

Latest DXB ASX Announcements

5 Oct 2026 · 8:56 amCompany Update
First Patient Reaches Four Years in DMX-200 Clinical Program
5 Oct 20268:56 amFirst Patient Reaches Four Years in DMX-200 Clinical ProgramCompany Update
28 Sept 2026 · 2:34 pmSecurities Administration
Notification regarding unquoted securities - DXB
28 Sept 20262:34 pmNotification regarding unquoted securities - DXBSecurities Administration
25 Sept 2026 · 2:42 pmMeetings & Governance
Notification of 2026 Annual General Meeting Date
25 Sept 20262:42 pmNotification of 2026 Annual General Meeting DateMeetings & Governance
23 Sept 2026 · 8:44 amPresentations
Dimerix Presents at ASX SMIDcaps Conference 2026
23 Sept 20268:44 amDimerix Presents at ASX SMIDcaps Conference 2026Presentations
23 Sept 2026 · 8:36 amCapital Raising
Dimerix Draws Down A$17M Under Non-Dilutive Funding Facility
23 Sept 20268:36 amDimerix Draws Down A$17M Under Non-Dilutive Funding FacilityCapital Raising
22 Sept 2026 · 3:46 pmCapital Raising
Waiver of Listing Rule 10.1 Granted
22 Sept 20263:46 pmWaiver of Listing Rule 10.1 GrantedCapital Raising
16 Sept 2026 · 8:31 amPresentations
Dimerix Presents at E&P Healthcare Conference 2026
16 Sept 20268:31 amDimerix Presents at E&P Healthcare Conference 2026Presentations
14 Sept 2026 · 8:39 amCompany Update
Dimerix DMX-652 Granted Mexican Composition of Matter Patent
14 Sept 20268:39 amDimerix DMX-652 Granted Mexican Composition of Matter PatentCompany Update
7 Sept 2026 · 8:51 amPresentations
Dimerix Investor Presentation
7 Sept 20268:51 amDimerix Investor PresentationPresentations
4 Sept 2026 · 5:10 pmOther
S&P DJI Announces September 2026 Quarterly Rebalance
4 Sept 20265:10 pmS&P DJI Announces September 2026 Quarterly RebalanceOther
4 Sept 2026 · 9:17 amCapital Raising
Dimerix Secures A$34 Million Non-Dilutive Funding Facility
4 Sept 20269:17 amDimerix Secures A$34 Million Non-Dilutive Funding FacilityCapital Raising
2 Sept 2026 · 8:43 amTrading Halt / Suspension
Trading Halt
2 Sept 20268:43 amTrading HaltTrading Halt / Suspension
27 Aug 2026 · 8:56 amCompany Administration
Appendix 4G and Corporate Governance Statement
27 Aug 20268:56 amAppendix 4G and Corporate Governance StatementCompany Administration
27 Aug 2026 · 8:56 amFinancial Results
Appendix 4E and 2026 Annual Report
27 Aug 20268:56 amAppendix 4E and 2026 Annual ReportFinancial Results
20 Aug 2026 · 9:13 amCompany Update
Dimerix Receives US$10M Upfront Payment from Everest
20 Aug 20269:13 amDimerix Receives US$10M Upfront Payment from EverestCompany Update

View complete DXB announcement history →

DIMERIX LIMITED

DXB Share Price

DXB News & Analysis

Dimerix (ASX: DXB) Secures A$34 Million Clinical Funding Facility

Latest DXB ASX Announcements